Moxifloxacin vs. Polytrim for Conjunctivitis
Recruitment status was Recruiting
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
|Study Design:||Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
|Official Title:||A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.|
- Clinical Cure [ Time Frame: 10 days ] [ Designated as safety issue: No ]
- Microbiological cure [ Time Frame: 10 days ] [ Designated as safety issue: No ]
|Study Start Date:||March 2007|
|Estimated Study Completion Date:||March 2012|
|Primary Completion Date:||March 2009 (Final data collection date for primary outcome measure)|
|Active Comparator: 1||
1-2 drops three times a day for 8-10 days.
|Active Comparator: 2||
1-2 drops four times a day for 8-10 days.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00581542
|Contact: Francis Gigliotti, MD||585-275-5944||Francis_gigliotti@urmc.rochester.edu|
|Contact: Barbra L Murante, RN||585-275-1549||Barbra_murante@urmc.rochester.edu|
|United States, New York|
|University of Rochester||Recruiting|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Francis Gigliotti, MD||University of Rochester|